Fractyl Health, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Fractyl Health, Inc. | GUTS - NASDAQ |
$14.00-$16.00 | $15.00 | $13.75 | 7.33 million | 2/2/2024 |
| BofA Securities, Morgan Stanley, Evercore ISI | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2023-12-14 Terms Added 2024-01-29 | ||||||
Fractyl Health, Inc. Quote & Chart - Click for current quote - GUTS
IPO Boutique aggregates information on public companies and private companies, such as "GUTS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Fractyl Health, Inc. (adapted from Fractyl Health, Inc. prospectus):
They are a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "GUTS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.